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Summary: We analysed the results of surveys on creatinine held in The Netherlands during the years 1992, 1993
and 1994. Assay results of 113 samples were reviewed: 88 human sera and 25 samples of animal origin. The results
of 5 creatinine assays, 4 based on the Jaffe reaction and 1 enzymatic procedure, are discussed.
The enzymatic assay showed by far the best performance, while some of the Jaffe methods differed considerably.
All results were evaluated by reference to a HPLC-based selected method for creatinine.
Our study shows the need for caution when applying survey performance criteria for creatinine.
Introduction
In two earlier publications we described the influence of
a number of factors on the accuracy of various creatinine
assays developed for routine use in clinical chemistry (1,
2). We also questioned the value of quality assessment
specimens for creatinine assays.
Since these earlier studies provided only limited data
on accuracy-influencing factors and the value of quality
assessment specimens, and in view of the large variation
of results, especially in some modifications of the Jaffe
reaction, we decided to study these aspects in greater
detail in a wider setting.
Here, we describe the cooperation, between three
laboratories, all participating in the serum chemistry
section of the Dutch Quality Assessment Founda-
tion (SKZL) (3). The results submitted during the
years 1992, 1993 and 1994 were compared with those
obtained with our high performance liquid chromatog-
raphy (HPLC) based selected method for creatinine
(4).
In addition, all samples under study were analysed
separately with the instruments also used in our previ-
ous study i.e. the DuPont Dimension and the Merck
ELAN.
Materials and Methods
Materials
One hundred and thirteen control sera were included in this study,
25 of animal origin, 88 of human origin. During the years 1992,
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1993 and 1994 they were distributed in the normal way by the
official Quality Assessment Foundation in The Netherlands to all
participating laboratories.
Methods
Five routine methods for creatinine were applied with the
following instruments:
1. Bayer-Technicon Chem-1 with a Jaffe reaction based method
2. Boehringer Mannheim Hitachi 717 and 747 with a Jaffe reaction
based method
3. DuPont Dimension with an enzymatic method
4. DuPont Dimension with a Jaffe reaction based method
5. Merck ELAN with a Jaffe reaction based method
Methods 1, 2, 4 and 5 were routine procedures as supplied by the
various manufacturers. Method 3 is a home made adaptation of
the Boehringer Mannheim enzymatic method (creatininase) to the
Dimension (5). All instruments were run according to the manufac-
turers' instructions. r
Procedure
The results of methods 1, 2 and 3 were taken from the quality
control files of the three participating laboratories. Similarly, the
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HPLC results were taken from the Academic Hospital Rotterdam,
which is part of the National External Quality Assessment Scheme.
Extra samples were stored at -80 °C during 1992,1993 and 1994,
and used for the methods 4 and 5.
Statistical analysis
Regression analysis was done according to Passing & Bablok (6).
Results
We started by comparing the routine methods (methods
1, 2 and 3) with the HPLC selected method. All values
deviating more than 20% from the corresponding HPLC
result were redetermined. This figure of 20% was cho-
sen arbitrarily. In total 7 results proved to be clerical er-
rors.
Then, using the same set of specimens, creatinine was
determined on the Dimension (Jaffe method) and the
ELAN.
All regression equations are tabulated separately in ta-
ble 1.
In view of the clinical significance of low to medium
range creatinine concentrations, those samples of human
origin with HPLC values lower than 300 μπιοΙΛ were
plotted separately (figs, la—e).
The regression equations for the range 0-300 μπιοΐ/ΐ
are also included in table L
Discussion
Our results from the elaborated study generally confirm
those found earlier, thus providing a sounder basis for
evaluation. The enzymatic procedure for creatinine
scores better than the Jaffe reaction based assays with
the specimens used in the Dutch Quality Assessment
Scheme. There are also differences between the various
creatinine (Jaffe) methods.
Many samples showing deviations from the HPLC re-
sults are problematic for all Jaffe reaction based creati-
nine methods. Nevertheless, it is possible to construct a
worst-case scenario by comparing the Chem-1 data with
the ELAN, as in figure 2.
We assume that the differences in the results of the vari-
ous Jaffe methods are due to the assay design. They are
all kinetic measurements, but they differ considerably
with respect to sample and reagent volumes, reagent
concentrations and choice of reagents and type of mea-
surement (mono- vs. bichromatic and timing of absor-
bance readings). The ELAN does not employ a bilirubin
correction, the Hitachi and Chem-1 have chromatic cor-
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Fig. 2 Graphical presentation of human control serum results ob-
tained with the ELAN and the Chem-L
Regression equation: y = 1.1 Ix - 30.0; r = 0.89
x(mean) = 93 μηιοΐ/ΐ, y(mean) =110 μπιοΐ/ΐ
x(median) = 87 μτηοΐ/ΐ, y(median) = 66 μπιοΐ/ΐ
rections, while the Dimension reagent contains potas-
sium hexacyanoferrate(III) for bilirubin oxidation. Due
to the influence of bilirubin, the ELAN showed con-
siderable deviations from the HPLC values, especially
with two extreme specimens containing 222 and 343
μτηοΐ bilirubin per litre; specimens with bilirubin values
of about 100 μιηοΐ/ΐ (6 in total) also showed discrepant
creatinine values.
Most of the deviating results for all methods, however,
could not be attributed to interference by bilirubin. Most
of the human serum samples were pooled left-over pa-
tient samples, sometimes spiked with additional material
like enzymes, bilirubin and sucrose. This makes it nearly
impossible to understand the cause of the deviation.
However, the findings with these human samples do
show again the limitations of the Jaffe reaction based
creatinine methods in the daily routine of a laboratory.
It is also clear from figure 2 that the expression "Jaffe
method" is an inaccurate statement.
The commercial sera used, BioRad (Lyphochek and
Liquichek) and Beckman Decision, show an interesting
pattern. The various techniques showed particularly sub-
stantial differences in the analysis of BioRad products,
so that the use of these products in surveys may be ques-
tionable. Of course, this argument does not hold for the
normal application of these products in precision checks
of a procedure.
These results reveal once more the general difficulty
with most classical External Quality Assessment (EQA)
schemes. Issues of cost, stability and available analyte
concentration often necessitate the use of processed lyo-
philized control serum, which very often lack the re-
quired degree of commutability with the native human
serum specimens. As correctly pointed out by Tiiienpont
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and Stöckl (7, 8), present-day quality assessment
schemes expose the dilemma of which combination of
control material and target value to choose. This di-
lemma is particularly acute when the results of such
schemes are to be used for accreditation/licensing
purposes.
Summarizing, the enzymatic method for creatinine used
in the present survey scores higher than any of the Jaffe
reaction based methods, based on comparison with our
HPLC based selected method. For the Jaffe reaction
based methods, survey material must be chosen care-
fully and possibly selectively. Results from samples of
animal origin have not been described in detail, because
of the limited number used (n = 25); however, the re-
sults were generally similar to tho$e obtained with the
human serum samples.
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